Tohru Yoneyama

Has grant

Hirosaki University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Development of PSMA-targeting neutron capture tharapy based theranostics

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

Development of next generation BNCT targeted to the tumor endothelial cell

Open Date: 2020-04-01

Close Date: 2023-03-31

Grant: Close

分子標的ホウ素中性子捕捉療法の開発

Open Date: 2019-06-28

Close Date: 2023-03-31

Grant: Close

Development of glycomolecule-based liquid biopsy marker for evaluation of prostate cancer malignancy

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

Tumor targeting using boron neutron capture therapy

Open Date: 2017-04-01

Close Date: 2020-03-31

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Naoki Fujita

Assistant Professor

Hirosaki University Graduate School of Medicine

JAPAN

View details

Koji Hatano

Osaka University Graduate School of Medicine

JAPAN

View details

Chikara Ohyama

Hirosaki University Graduate School of Medicine

JAPAN

View details

Teppei Okamoto

Tohoku University Hospital

JAPAN

View details

Yuki Tobisawa

Gifu University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tohru Yoneyama

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (9)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy

Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer

TMEM2 expression is downregulated as bladder cancer invades the muscle layer

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non–muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer

Collaborators (5)

Naoki Fujita

Koji Hatano

Chikara Ohyama

Teppei Okamoto

Yuki Tobisawa

Make your next move.